IMIDAZO[5,1-a]IZOXINOLIN HOSILALARINING COX-2 OQSILI BILAN BOG‘LANISH XUSUSIYATLARINI MOLEKULYAR DOKING USULI YORDAMIDA TADQIQ ETISH
Mirzoqulov S. M., Asrayeva N. A., Jo‘rayeva H. A. & Tuxtayev D. B.
Annotatsiya
Mazkur tadqiqot ishida imidazo[5,1-a]izoxinolin hosilalarining Siklooksigenaza-2 (COX-2) oqsili bilan o‘zaro ta’siri molekulyar doking usuli yordamida o‘rganildi. Tadqiqot davomida ligandlarning COX-2 faol markaziga bog‘lanish energiyasi va o‘zaro ta’sirlari tahlil qilindi. Molekulyar doking natijalari ayrim hosilalarning oqsil faol markazi bilan barqaror kompleks hosil qilishini va yuqori affinitetga ega ekanligini ko‘rsatdi. Olingan natijalar imidazo[5,1-a]izoxinolin hosilalarining yallig‘lanishga qarshi potensial COX-2 ingibitorlari sifatida istiqbolli ekanligini ko‘rsatadi.
Adabiyotlar
- Nandakishore R, Yalavarthi PR, Kiran YR, Rajapranathi M (2014) Selective cyclooxygenase inhibitors: Current status. Curr Drug Discov Technol 11(2):127–132.
- Kirkby NS, et al. (2012) Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proc Natl Acad Sci USA 109(43):17597–17602.
- Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats:Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119(3):706–714.
- Scarpignato C, et al.; International NSAID Consensus Group (2015) Safe prescribing of non steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus ad dressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med 13:55.
- Keri R.S., Chand K., Budagumpi S., Nagaraja B.M. An overview of biologically active benzo[g]imidazo[1,2-a]quinoline and imidazo[4,5-c]isoquinoline derivatives. European Journal of Medicinal Chemistry, 2015, 89, 207–251.
- Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: a powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157.